Dasatinib 59651-0543-15
- Manufacturer
- Aurobindo Pharma Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 22, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA216547
Need to source Dasatinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dasatinib | 50 mg/1 |
Drug Class
Cytochrome P450 3A4 Inhibitors [MoA]Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Selected Package
59651-0543-15Selected1 BLISTER PACK in 1 CARTON (59651-543-15) / 15 TABLET in 1 BLISTER PACK
Other packages for this product(1)
60 TABLET in 1 BOTTLE (59651-543-60)